High serum IgG4 concentrations in patients with sclerosing pancreatitis
Efficacy and tolerability of a cream containing modified glutathione (GSHC4), betaglycyrrhetic, and azelaic acids in mildtomoderate rosacea: a pilot, assessorblinded, VISIA and ANTERA 3D analysis, twocenter study (The Rosazel Trial) J Cosmet Dermatol
On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
Neither blend is "better" than the other in absolute terms
Discover high-quality magnesium products for daily use
Reliable sourcing, responsive communication, and operational consistency are often key factors influencing procurement decisions